Two of the world’s largest generics makers are looking to lay their hands on the largest generics manufacturing plant in Latin America, sources tell Reuters,…

Since it bought out Ranbaxy Laboratories last year, Sun Pharma has been in the process of trimming back its manufacturing network of nearly 50 plants to a more…

Finland’s Fermion plans to spend €30 million to expand an API plant in Hanko--its largest investment in company history--in a move to support current and…

Mylan has struck a $1 billion deal to get the dermatology business of Renaissance Acquisition Holding. But it is getting more than a portfolio of generic meds…

Swedish CDMO Recipharm will get its first U.S. site with a deal to buy operations API and development operations from India’s Kemwell.

Teva expects to close on its buyout of Allergan’s generic drug business, but for now, Allergan is responsible for the recall of more than 50 lots, consisting…

Reuters reports that Swiss CDMO Lonza is interested in buying U.S.-based Catalent

M&A